会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Method of separating cells from blood using a filter having a changeable
porosity
    • 使用具有可变孔隙率的过滤器从血液中分离细胞的方法
    • US6139757A
    • 2000-10-31
    • US999529
    • 1997-03-28
    • Yoshitaka OhmuraNoboru TaguchiTadashi Sameshima
    • Yoshitaka OhmuraNoboru TaguchiTadashi Sameshima
    • A61M1/00A61M1/34B01D29/01B01D61/18B01D63/08B01D69/02B01D69/12C12M3/06G01N1/10B01D25/26
    • B01D69/12B01D61/18B01D69/02G01N33/491
    • A method of separating cells from blood by using a filter apparatus having first and second ports and a filter member therebetween having a changeable porosity. The filter member includes a stack of porous polymer sheets that preferably has a gradient of a physical or chemical characteristic in the direction of stacking. This can include a gradient in porosity, hydrophilicity or zeta potential. In a first step, blood is filtered through the apparatus when the filter member is set to a compressive state having a first porosity capable of capturing the objective cells. In a later step, the filter member is then set to a non-compressive state having a second porosity, higher than the first, for recovering the objective cells. The change in porosity results from the enlargement or reduction of the diameter of the pores of the filter member. The method can also include washing the filter member when the member is set to a porosity that is higher than the first porosity but lower than the second porosity.
    • 通过使用具有第一和第二端口的过滤装置和其间具有可变孔隙率的过滤器构件从血液中分离细胞的方法。 过滤构件包括一堆多孔聚合物片,其优选地具有在堆叠方向上的物理或化学特性的梯度。 这可以包括孔隙度,亲水性或ζ电位的梯度。 在第一步骤中,当过滤构件被设置为具有能够捕获目标单元的第一孔隙的压缩状态时,通过设备过滤血液。 在随后的步骤中,然后将过滤器构件设置为具有高于第一孔隙率的第二孔隙率的非压缩状态,用于回收目标单元。 孔隙度的变化是由于过滤构件的孔的直径的扩大或减小。 该方法还可以包括当将构件设定为高于第一孔隙度但低于第二孔隙率的孔隙率时,洗涤过滤构件。
    • 4. 发明授权
    • Immunoglobulin adsorbent and adsorption apparatus
    • 免疫球蛋白吸附剂和吸附装置
    • US4705628A
    • 1987-11-10
    • US849068
    • 1986-04-07
    • Yuichi YamamotoTadashi Sameshima
    • Yuichi YamamotoTadashi Sameshima
    • B01J20/26A61M1/36B01J20/10B01J20/281B01J20/32G01N33/543G01N33/552G01N33/564B01D15/00
    • B01J20/3263A61M1/3679G01N33/54353G01N33/552G01N33/564A61M2202/0417
    • For the treatment of various diseases including autoimmune diseases such as myathenia gravis, articular rhematism, lupus erythematosus, etc., immunity-related diseases such as glumerulonephritis, bronchial asthma, polyneuritis, etc., organ transplantation such as transplanted kidney rejection, AOB incompatibility bone marrow transplantation, etc., tumor, hypertension, and hepatic insufficiency, immunoglobulin adsorbents comprising a hydroxyl-containing water-insoluble carrier to which a diamine compound having the general formula:NH.sub.2 (CH.sub.2).sub.n NH.sub.2wherein n is an integer having a value of 3 to 9 is attached through a silane coupling agent or a derivative thereof, to which diamine a heterocyclic compound is attached through a difunctional reagent, are useful as they can selectively and efficiently adsorb specific proteins such as immunoglobulins and immune complexes which are pathogenic substances in the diseases, exhibit minimized non-specific adsorption, and are safe and easy to sterilize.
    • 用于治疗诸如重症肌无力,关节性血症,红斑狼疮等自身免疫性疾病的各种疾病,免疫相关疾病如脑性脑炎,支气管哮喘,多发性神经炎等,器官移植如移植肾排斥反应,AOB不相容性骨 骨髓移植等,肿瘤,高血压和肝功能不全,包含含羟基的水不溶性载体的免疫球蛋白吸附剂,其中具有通式:NH 2(CH 2)n NH 2的二胺化合物,其中n是具有值3的整数 至9通过硅烷偶联剂或其衍生物通过双官能试剂连接到杂环化合物上的二胺是有用的,因为它们可以选择性地和有效地吸附特异性蛋白质,例如免疫球蛋白和作为病原体的免疫复合物 疾病,展示最小化非特异性吸附,并且是安全和容易灭菌 。